[HTML][HTML] Virus-like particle vaccinology, from bench to bedside
MO Mohsen, MF Bachmann - Cellular & molecular immunology, 2022 - nature.com
Virus-like particles (VLPs) have become key tools in biology, medicine and even
engineering. After their initial use to resolve viral structures at the atomic level, VLPs were …
engineering. After their initial use to resolve viral structures at the atomic level, VLPs were …
[HTML][HTML] Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective
N Ebrahimi, Z Yousefi, G Khosravi, FE Malayeri… - Frontiers in …, 2023 - frontiersin.org
Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health
problems like genital warts and cancer. The national immunization schedules for individuals …
problems like genital warts and cancer. The national immunization schedules for individuals …
[HTML][HTML] Heparan sulfate and sialic acid in viral attachment: Two sides of the same coin?
IE Ramos-Martínez, E Ramos-Martínez… - International Journal of …, 2022 - mdpi.com
Sialic acids and heparan sulfates make up the outermost part of the cell membrane and the
extracellular matrix. Both structures are characterized by being negatively charged, serving …
extracellular matrix. Both structures are characterized by being negatively charged, serving …
[HTML][HTML] Navigating therapeutic strategies: HPV classification in head and neck cancer
H Tabatabaeian, Y Bai, R Huang, A Chaurasia… - British Journal of …, 2024 - nature.com
Abstract The World Health Organisation recognised human papillomavirus (HPV) as the
cause of multiple cancers, including head and neck cancers. HPV is a double-stranded DNA …
cause of multiple cancers, including head and neck cancers. HPV is a double-stranded DNA …
[HTML][HTML] Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?
Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …
most common sexually transmitted infections (STIs) in both males and females, and the most …
[HTML][HTML] Human papilloma virus: an unraveled enigma of universal burden of malignancies
I Khan, R Harshithkumar, A More, A Mukherjee - Pathogens, 2023 - mdpi.com
HPV, or Human Papilloma Virus, has been the primary causative agent of genital warts and
cervical cancer worldwide. It is a sexually transmitted infection mainly affecting women of …
cervical cancer worldwide. It is a sexually transmitted infection mainly affecting women of …
[HTML][HTML] Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review
Therapeutic vaccination is one of the most effective immunotherapeutic approaches, second
only to immune checkpoint inhibitors (ICIs), which have already been approved for clinical …
only to immune checkpoint inhibitors (ICIs), which have already been approved for clinical …
Current Status of Human Papillomavirus–Targeted Therapies Development in Head and Neck Cancer
JC Park, B Bertaux, J Park, S Park - JCO Precision Oncology, 2023 - ascopubs.org
PURPOSE While the incidence of smoking-related head and neck squamous cell carcinoma
(HNSCC) has been declining, that of human papillomavirus (HPV)–mediated HNSCC has …
(HNSCC) has been declining, that of human papillomavirus (HPV)–mediated HNSCC has …
[HTML][HTML] Sleep deprivation and NLRP3 inflammasome: Is there a causal relationship?
In the modern era, sleep deprivation (SD) is one of the most common health problems that
has a profound influence on an individual's quality of life and overall health. Studies have …
has a profound influence on an individual's quality of life and overall health. Studies have …
Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies
J Wang, L Ma, Y Chen, R Zhou, Q Wang… - Life Science …, 2024 - life-science-alliance.org
Human papillomavirus (HPV) infections account for several human cancers. There is an
urgent need to develop therapeutic vaccines for targeting preexisting high-risk HPV (such as …
urgent need to develop therapeutic vaccines for targeting preexisting high-risk HPV (such as …